We currently use a mixture of direct spreads, cytospins and SurePath® Liquid Based Cytology (LBC) technology in our sample preparation.
All samples are prepared in a Containment level 3 room with Class 1 microbiological safety cabinets. Our research activity includes:
- Use of LBC technology in next generation sequencing
- Ongoing research project called DETECT study to screen women presenting with post-menopausal bleeding for evidence of endometrial carcinoma. This study is set to widen to a multicentre project pending funding in 2018.
Molecular testing – Non-gynaecological Cytology
The non-gynaecological cytology department can facilitate a number of molecular tests on cytology samples due to our close working relationship with the Manchester Centre for Genomic Medicine, The Christie Hospital NHS Foundation Trust and the Patterson Institute.
It is strongly recommended that the clinicians convey any requests for molecular tests to the attending BMS for any FNA cytology samples or to the consultant cyto/histopathologists for any exfoliative cytology samples, either by indication on the request card or by telephone.
(Last reviewed 27th February 2018)